NCT00005879 2017-05-30
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
University of Kansas Medical Center
Phase 2 Completed
Clinical Trials
3 trialsNCT00190697 2007-05-25
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
Eli Lilly and Company
Phase 4 Completed
NCT00034125 2006-07-19
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Eli Lilly and Company
Phase 3 Completed